TipRanks
Medistim ASA (DE:MD1)
FRANKFURT:MD1
Germany Market

Medistim ASA (MD1) Income Statement

1 Followers

Medistim ASA Income Statement

Last quarter (Q2 2026), Medistim ASA's total revenue was kr202.03M, an increase of 19.49% from the same quarter last year. In Q2, Medistim ASA's net income was kr52.20M. See Medistim ASA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 699.77Mkr 562.60Mkr 521.11Mkr 486.26Mkr 417.82M
Gross Profit
kr 321.19Mkr 448.92Mkr 408.83Mkr 379.78Mkr 320.70M
Operating Expenses
kr 375.40Mkr 311.41Mkr 277.39Mkr 238.53Mkr 204.43M
Depreciation and Amortization
kr 22.69Mkr 24.51Mkr 23.66Mkr 17.34Mkr 17.36M
EBITDA
kr 218.89Mkr 155.59Mkr 155.10Mkr 163.77Mkr 132.03M
Operating Income
kr 196.20Mkr 131.08Mkr 131.44Mkr 141.25Mkr 116.28M
Other Income/Expenses
kr 10.65Mkr 3.17Mkr 3.77Mkr 4.80Mkr -2.21M
Pretax Income
kr 206.85Mkr 134.25Mkr 135.21Mkr 146.05Mkr 114.07M
Net Income
kr 159.21Mkr 103.83Mkr 103.82Mkr 113.97Mkr 90.90M
Per Share Metrics
Basic EPS
kr 8.71kr 5.67kr 5.67kr 6.25kr 4.99
Diluted EPS
kr 8.71kr 5.67kr 5.67kr 6.24kr 4.98
Weighted Average Shares Outstanding
18.28M 18.31M 18.30M 18.25M 18.22M
Weighted Average Shares Outstanding (Diluted)
18.28M 18.31M 18.30M 18.28M 18.25M
Currency in NOK

Medistim ASA Earnings and Revenue History